Imaging physicians (radiologists and nuclear medicine specialists) at some Canadian bone mineral density (BMD) centers find themselves under pressure to report fracture risk using the Fracture Risk Assessment Tool (FRAX) tool rather than the Canadian Association of Radiologists and Osteoporosis Canada (CAROC) platform. The question arises: is this a realistic expectation? Dual x-ray absorptiometry (DXA) is the most widely used method for measuring BMD, and has 3 main roles: diagnosis of osteoporosis, estimation of fracture risk, and monitoring of response to treatment. The 2010 clinical practice guidelines published by the Scientific Advisory Council of Osteoporosis Canada endorse the use of 2 related tools for fracture risk estimation: 1) the Canadian FRAX tool and 2) the CAROC tool [1] .
The Canadian FRAX tool is a derivative of FRAX, which was launched at the University of Sheffield in 2008 [2] . The World Health Organization (WHO) clarified recently that the FRAX tool ''has not been developed, endorsed, evaluated or validated by WHO, notwithstanding any public statements and claims to that effect'' [3] . FRAX, a computer-based algorithm, employs sex, age, body mass index, and an additional 7 clinical risk factors (previous fragility fracture, parental hip fracture, current smoking, prolonged use of glucocorticoids, rheumatoid arthritis, secondary osteoporosis, and excessive alcohol use), with the optional input of femoral neck BMD, to estimate 10-year fracture risk. The latter is expressed as a discrete percentage for major osteoporotic fracture (spine, hip, forearm, proximal humerus) and for hip fracture alone. Because hip fracture rates in particular are specific to any given country, the FRAX algorithm has been calibrated to the Canadian population, resulting in a Canada-specific instrument [4] .
The CAROC tool was constructed and validated from the same data as the Canadian FRAX risk assessment tool, and is in essence a simplified version of the latter, designed for use when it is not practical to employ the full Canadian FRAX tool [5] . The CAROC tool uses sex, age, and femoral neck T-score, along with 2 clinical risk modifiers (prior fragility fracture and prolonged recent corticosteroid therapy) to estimate 10-year fracture risk for major osteoporotic fracture. A discordantly low lumbar spine T-score has the potential to raise fracture risk. Patients are assigned to 1 of 3 risk categories: low risk (<10%), moderate risk (10%-20%), or high risk (>20%).
The 2 risk assessment tools showed a high overall degree of concordance when compared initially, and either was recognized as being appropriate to stratify patients for subsequent management. Nevertheless the 2 instruments, although complementary, are inherently different and can never be in perfect agreement. A recent analysis from the Manitoba Bone Mineral Density Database concluded that FRAX provides a modest but clinically relevant improvement over CAROC in fracture risk prediction [6] . Despite the controversies it has engendered [7] , FRAX has now been calibrated for well over 3-dozen countries around the world and is considered the best known of the various fracture risk algorithms.
The current Canadian Association of Radiologists Technical Standards for Bone Mineral Densitometry Reporting, although recognizing FRAX, endorse CAROC as the method of choice for estimating fracture risk [8] . The standards advise that in addition to information provided by the referring physician, the facility identify key clinical risk factors and other critical information by means of a selfreported patient questionnaire that is typically overseen by the technologist. The minimum such data required to assist with fracture risk estimation are fracture history, the prolonged use of glucocorticoids, and treatment with boneactive medication. Some facilities go beyond this and attempt to identify the clinical risk factors used for FRAX assessment, particularly if FRAX software is embedded in their DXA scanners.
However, there are significant limitations to accurate data collection in daily BMD practice, where contact with the patient is by necessity of a cursory nature, and the validity of the information provided cannot always be confirmed. Regarding the 2 clinical risk factors required by the CAROC tool, it may not be possible to determine if a reported fracture was a fragility fracture, and not all patients are able to reliably report their medication history. The enhanced data collection required for FRAX compounds this dilemma. This is particularly true for rheumatoid arthritis, which many patients confuse with osteoarthritis. Clinical or laboratory evidence is typically required to support the diagnosis of rheumatoid arthritis, evidence that is usually not available to the imaging physician. In the FRAX category of secondary osteoporosis, it is our experience that patients often confuse thyroid disease with hyperparathyroidism, and may not distinguish between hyper-and hypothyroidism. Information regarding the degree of alcohol consumption is often inaccurate. Similar limitations were noted by the expert developers of the Canadian FRAX tool, who acknowledged the potential for misclassification in certain clinical risk factors [4] .
All fracture risk tools are by their nature imperfect, and in one comprehensive review no convincing evidence could be found to favor more complex tools over simpler ones [9] . It has been noted in general that the usefulness of risk factor assessment in medicine depends on both the diagnostic accuracy of the instrument and its ease of use [10] . One practical limitation to the use of FRAX compared with CAROC is that the former requires data entry in 12 online boxes to estimate fracture risk. With the CAROC tool, fracture risk can be determined visually without the need for an additional computer monitor, by reference to risk tables or graphs incorporating age, sex, and femoral neck T-score. Another limitation to enhanced data collection arises in radiology clinics serving large metropolitan centers, where many languages may be spoken, and accurate translation is problematic.
We believe that the CAROC tool is the more practical fracture risk assessment tool for imaging physicians reporting DXA scans. These individuals do not usually have sufficient knowledge of the patient's medical history to permit accurate entry of some of the important variables required by the FRAX tool. In addition, the relative ease of use of CAROC is a valuable asset in most BMD settings. However we acknowledge the international status of FRAX and its value to experts in bone health, who, in specialist settings, are in the best position to apply the important clinical judgement required to advise on preventive or therapeutic intervention.
